This week's sale of the technology behind Dolly, the first cloned sheep, to an American biotech company should bring more than Pounds 20 million to the institute where she was born, it is estimated. The purchase of Roslin Bio-Med by California's Geron Corporation, which sponsored the scientists who last year cultivated human embryonic stem cells, should accelerate the development of new transplantation therapies for numerous degenerative diseases.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber? Login